Global Advanced Glycation End Products Market to Surpass US$ 2,130.1 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE–(BUSINESS WIRE)–#AdvancedGlycation–According to Coherent Market Insights, the global advanced glycation end products market is estimated to be valued at US$ 1,368.5 million in 2020 and is expected to exhibit a CAGR of 7.3% over the forecast period (2020-2027).

Key Trends and Analysis of the Global Advanced Glycation End Products Market:

Key trends in the market include increasing launches of advanced glycation end products, increasing number of chronic diseases, research and development in advanced glycation end products by major players, and increasing geriatric population. These factor are expected to drive growth of the market over the forecast period.

The rising incidence of chronic diseases such as cancer, cardiac conditions, and diabetes, among others is a major factor which is expected to drive the market growth. For instance, according to the National Center for Biotechnology Information (NCBI), 2020, in 2017, globally, around 126 million people suffered from ischemic heart disease (1,655 per 100,000), which constituted to 1.72% of the total world population.

Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.

Buy-Now this Research Report for complete market Insights @

https://www.coherentmarketinsights.com/insight/buy-now/4350

Key Market Takeaways:

The global advanced glycation end products market is expected to exhibit a CAGR of 6.3% over the forecast period, owing to increasing number of diabetic patients globally. For instance, according to the Cancer Research UK, in 2014, around 357,000 new cancer cases were diagnosed in the U.K., accounting for 980 diagnosed cases per day. Breast, prostate, lung, and bowel cancers together accounted for over 53% of the total cancers in the U.K.

Among regions, North America is expected to hold dominant position in the global market over the forecast period, owing to increasing number of diabetic patients in the region. For instance, according to the American Diabetes Association, in 2018, around 34.2 million people in the U.S. (representing 10.5% of the total U.S. population) suffered from diabetes.

Competitive Landscape:

Key players operating in the global advanced glycation end products market include Merck KGaA, Diagnoptics Technologies B.V., Cell Biolabs, Inc., Shanghai Korain Biotech Co., Ltd, Scent-Sations, Inc., Z.I. de la Nau, and KOKEN CO., LTD. among others.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4350

Market Segmentation:

• Global Advanced Glycation End Products Market, By Type:

• Non-fluorescent AGEs
  • Carboxymethyl-lysine (CML)
  • Carboxyethyl-lysine (CEL)
  • Pyrraline
• Fluorescent AGEs
  • Pentosidine
  • Methylglyoxal-lysine dimer (MOLD)

• Global Advanced Glycation End Products Market, By Application:
  • Diabetic Complications
  • Cancer
  • Bone Diseases
  • Neurodegenerative Diseases
  • Others

• Global Advanced Glycation End Products Market, By End User:
  • Hospitals
  • Specialty Clinics
  • Homecare Settings

• Global Advanced Glycation End Products Market, By Region:
  • North America
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa

Related Market Intelligence Reports:

Glucosamine Market, by Product Type (Powder, Tablets, Capsules, and Liquid), by Application (Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/glucosamine-market-4345

Pediatric Electrolyte Solution Market, by Type (Sodium, Chloride, Potassium, Calcium, and Magnesium), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/pediatric-electrolyte-solution-market-4344

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. Our client base includes players from across various business verticals in over 57 countries worldwide.

Contacts

Mr. Shah

Senior Client Partner – Business Development

Coherent Market Insights

Phone:
US: +1-206-701-6702

UK: +44-020-8133-4027

Japan: +81-050-5539-1737

India: +91-848-285-0837

Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter